Literature DB >> 26816931

Evaluation of Endothelial and Platelet Derived Microparticles in Patients with Acute Coronary Syndrome.

Melvin George1, M R Ganesh2, Aruna Sridhar3, Amrita Jena3, Muthukumar Rajaram3, Elangovan Shanmugam4, V E Dhandapani5.   

Abstract

BACKGROUND: Microparticles (MP) are a nuclear fragments of membrane released by the damaged cell during stress. Elevated levels of MP have been found in patients with acute coronary syndrome (ACS) owing to the damage in the endothelium. AIM: To determine if the levels of endothelial and platelet microparticles (EMP & PMP) in patients with ACS influenced the severity of the disease.
MATERIALS AND METHODS: This was a prospective cohort study performed in 63 ACS patients (ST elevation myocardial infarction- STEMI-28, non ST elevation myocardial infarction -NSTEMI-35). After obtaining consent, blood samples were collected from the patients and processed by flow cytometry.
RESULTS: The NSTEMI group had higher levels of EMP {792.11(327.59-1661.49) vs 300.35 (176.3-550.46), p=0.001} and PMP {218.87(86.65-439.77) vs 114.45(50.34-196.75), p= 0.007} as compared to the STEMI group. However, it was found that the EMP (r=-0.438, p=0.001) and PMP (r= -0.316, p=0.024) negatively correlated with Global Registry of Acute Coronary Events score (GRACE in-hospital score) for the entire cohort.
CONCLUSION: The levels of microparticles are elevated in ACS patients and may reflect a protective effect in patients with acute coronary syndrome.

Entities:  

Keywords:  Endothelial microparticles; GRACE Score; Myocardial infarction; Platelet microparticles

Year:  2015        PMID: 26816931      PMCID: PMC4717789          DOI: 10.7860/JCDR/2015/14493.6920

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  16 in total

1.  Differences in microparticle release in patients with acute coronary syndrome and stable angina.

Authors:  Luigi Marzio Biasucci; Italo Porto; Luca Di Vito; Giovanni Luigi De Maria; Antonio Maria Leone; Giovanni Tinelli; Alessandra Tritarelli; Giuliana Di Rocco; Francesco Snider; Maurizio C Capogrossi; Filippo Crea
Journal:  Circ J       Date:  2012-06-05       Impact factor: 2.993

2.  Endothelial progenitor cells and left ventricle function in patients with acute myocardial infarction: potential therapeutic considertions.

Authors:  Wiktor Kuliczkowski; Roksolana Derzhko; Iwona Prajs; Maria Podolak-Dawidziak; Victor L Serebruany
Journal:  Am J Ther       Date:  2012-01       Impact factor: 2.688

Review 3.  Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells.

Authors:  Dylan Burger; Rhian M Touyz
Journal:  J Am Soc Hypertens       Date:  2012-02-09

4.  Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes.

Authors:  Jan-Malte Sinning; Jan Losch; Katrin Walenta; Michael Böhm; Georg Nickenig; Nikos Werner
Journal:  Eur Heart J       Date:  2010-12-24       Impact factor: 29.983

Review 5.  Cell-derived microparticles in the pathogenesis of cardiovascular disease: friend or foe?

Authors:  Maarten E Tushuizen; Michaela Diamant; Augueste Sturk; Rienk Nieuwland
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01       Impact factor: 8.311

Review 6.  Circulating microparticles: pathophysiology and clinical implications.

Authors:  Andrea Piccin; William G Murphy; Owen P Smith
Journal:  Blood Rev       Date:  2006-11-22       Impact factor: 8.250

7.  P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.

Authors:  P Marc van der Zee; Eva Biró; Yung Ko; Robbert J de Winter; C Erik Hack; Augueste Sturk; Rienk Nieuwland
Journal:  Clin Chem       Date:  2006-01-26       Impact factor: 8.327

8.  Factors affecting the extent and severity of coronary artery disease in patients enrolled in the coronary artery surgery study.

Authors:  R E Vlietstra; R A Kronmal; R L Frye; A K Seth; F E Tristani; T Killip
Journal:  Arteriosclerosis       Date:  1982 May-Jun

9.  Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein.

Authors:  Ying Cui; Lihui Zheng; Ming Jiang; Ru Jia; Xiao Zhang; Qishan Quan; Guiqin Du; Dongjin Shen; Xiaodan Zhao; Wenying Sun; Hongwei Xu; Lijuan Huang
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

Review 10.  Emerging risk factors for cardiovascular diseases: Indian context.

Authors:  Sushil Gupta; Ramesh Gudapati; Kumar Gaurav; Manoj Bhise
Journal:  Indian J Endocrinol Metab       Date:  2013-09
View more
  4 in total

Review 1.  Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and Thrombosis.

Authors:  Lina Badimon; Rosa Suades; Eduardo Fuentes; Iván Palomo; Teresa Padró
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

2.  Multimarker approach for the prediction of microvascular obstruction after acute ST-segment elevation myocardial infarction: a prospective, observational study.

Authors:  Hans-Josef Feistritzer; Sebastian Johannes Reinstadler; Gert Klug; Martin Reindl; Sebastian Wöhrer; Christoph Brenner; Agnes Mayr; Johannes Mair; Bernhard Metzler
Journal:  BMC Cardiovasc Disord       Date:  2016-11-28       Impact factor: 2.298

Review 3.  Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans.

Authors:  Ilaria Marrocco; Fabio Altieri; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2017-06-18       Impact factor: 6.543

Review 4.  The Impact of Vascular Disease Treatment on Platelet-Derived Microvesicles.

Authors:  Justyna Rosińska; Maria Łukasik; Wojciech Kozubski
Journal:  Cardiovasc Drugs Ther       Date:  2017-12       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.